In light of the need to act quickly and efficiently to respond to the COVID-19 public health emergency, the US Food and Drug Administration (FDA) on Friday said that it anticipates that prior public participation will not be feasible or appropriate before FDA implements COVID-19-related guidance documents.
Although COVID-19-related guidance documents will be immediately implemented without prior public comment, FDA said it will still solicit comment, review all comments received and revise the guidance documents as appropriate…
Read more at RAPS.org